Advertisement

Fluorescent Derivatives of Sphingomyelin: Synthesis, Use as Substrates for Sphingomyelinase and for Diagnosis of Niemann-Pick Disease in Cultured Cells

  • Thierry Levade
  • Rachel Klar
  • Arie Dagan
  • Sara Cherbu
  • Shimon Gatt
Part of the NATO ASI Series book series (NSSA, volume 116)

Abstract

Several fluorescent derivatives of sphingomyelin have been synthesized and used as substrates for the acidic (lysosomal) or neutral (magnesium-dependent) sphingomyelinases of rat brain. These compounds were also successfully employed for demonstrating the deficiency of the enzyme in cells (skin fibroblasts or lymphoid cell lines) derived from patients with Niemann-Pick disease, Types A or B. The differences between the lipidotic and normal cells were demonstrated using cell extracts as well as intact, living cells “loaded” with the fluorescent sphingomyelin.

Keywords

Skin Fibroblast Human Skin Fibroblast Fluorescent Derivative Lymphoid Cell Line Culture Cell Extract 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

NPD

Niemann-Pick disease

SPM

sphingomyelin

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    S. Gatt, in “Phospholipids in the Nervous System, Vol. 1: Metabolism”, L.A. Horrocks et al., eds., Raven Press, New York, (1982).Google Scholar
  2. 2.
    S. Gatt, T. Dinur, and Z. Leibovitz-Ben Gershon, Biochim. Biophys. Acta, 531: 206 (1978).PubMedCrossRefGoogle Scholar
  3. 3.
    R.O. Brady, in “The Metabolic Basis of Inherited Disease, 5th ed.”, J.B. Stanbury et al., eds., McGraw-Hill, New York (1983).Google Scholar
  4. 4.
    S. Gatt, T. Dinur, and J. Kopolovic, J. Neurochem 31: 547 (1978).PubMedCrossRefGoogle Scholar
  5. 5.
    T. Levade, R. Salvayre, G. Lenoir, and L. Douste-Blazy, Biochim. Biophys. Acta, 793: 321 (1984).Google Scholar
  6. 6.
    T. Levade, R. Salvayre, J.C. Bes, M. Nezri, and L. Douste-Blazy, Pediatr. Res., 19: 153 (1985).PubMedCrossRefGoogle Scholar
  7. 7.
    T. Levade, R. Salvayre, and L. Douste-Blazy, Eur. J. Biochem., 149: 405 (1985).PubMedCrossRefGoogle Scholar
  8. 8.
    T. Levade, R. Salvayre, and L. Douste-Blazy, J. Neurochem., 40: 1762 (1983).PubMedCrossRefGoogle Scholar
  9. 9.
    S. Gatt, T. Dinur, and Y. Barenholz, Biochim. Biophys. Acta, 530: 503 (1978).PubMedCrossRefGoogle Scholar
  10. 10.
    S. Gatt, T. Dinur, and Y. Barenholz, Clin. Chem., 26: 93 (1980).PubMedGoogle Scholar
  11. 11.
    R. Cohen, Y. Barenholz, S. Gatt, and A. Dagan, Chem. Phys Lipids, 35: 371 (1984).PubMedCrossRefGoogle Scholar
  12. 12.
    S. Gatt and T. Gottesdiner, J. Neurochem., 21: 421 (1976).CrossRefGoogle Scholar
  13. 13.
    P. Bohlen, S. Stein, W. Dairman, and S. Udenfriend, Arch. Biochem. Biophys., 155: 213 (1973).PubMedCrossRefGoogle Scholar
  14. 14.
    T. Dinur, G.A. Grabowski, R.J. Desnick, and S. Gatt, Anal. Biochem., 136: 223 (1984).PubMedCrossRefGoogle Scholar
  15. 15.
    M.T. Vanier, R. Rousson, I. Garcia, G. Bailloud, M.C. Juge, A.Revol, and P. Louisot, Clin. Genet., 27: 20 (1985).PubMedCrossRefGoogle Scholar
  16. 16.
    M. Shinitzky, FEBS Lett, 85: 317 (1978).PubMedCrossRefGoogle Scholar
  17. 17.
    J.C. Maziere, C. Maziere, L. Mora, J.D. Routier, and J. Polonovski, Biochem. Biophys. Res. Commun., 108: 1101 (1982).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Thierry Levade
    • 1
  • Rachel Klar
    • 1
  • Arie Dagan
    • 1
  • Sara Cherbu
    • 1
  • Shimon Gatt
    • 1
  1. 1.Department of Membrane Biochemistry and NeurochemistryThe Hebrew University-Hadassah School of MedicineJerusalemIsrael

Personalised recommendations